Sabby Management, LLC Durect Corp Transaction History

Sabby Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$0.51 - $0.82 $67,269 - $108,158	-131,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.06 - $1.69 $25,678 - $40,940	24,225 Added 22.5%	131,900 $145,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $167,973 - $270,264	107,675 New	107,675 $168,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $207M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.